🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

First Report of Tirzepatide Hepatotoxicity with Jaundice pubmed.ncbi.nlm.nih.gov/38964597/ published by Robert Fontana. Convincing case w/significant liver injury. If you see a case, report to US FDA MedWatch LiverTox Lily Dara David Kleiner Raj VuppaLanchi Lilly Medical US

An excellent tool that I bookmarked Lauren Nephew MD, MSCE Raj VuppaLanchi Archita Desai Indiana University Gastroenterology and Hepatology. Michael Fralick thank you. Can you look into why my browser says it is an insecure site?

Important work from NASH CRN led by IU investigators

This week in key Covid publications and preprints: —Increased risk of major adverse cardiovascular events 3-years out, irrespective of severity ahajournals.org/doi/10.1161/AT… —7T MRI showing brainstem inflammation months after severe Covid academic.oup.com/brain/advance-… —Long Covid individuals

Dr Todd Stravitz is a brilliant researcher in ALF and an excellent clinician and mentor for over three decades at VCU. Truly inspiring contributions and yet so modest and humble.

Honored to present this year’s Leon Schiff State of the Art Lecture AASLD #TLM2024 on “Hepatic Encephalopathy”. Focus on changing paradigms that could ⬆️ patient voices, newer Rx & a holistic view to diagnosis. 🙏 W Ray Kim for the invite. Join me Nov18, 8am Pacific!

At the #TLM24 Diversity Reception, Professor Grace Su, president-elect of #AASLD, honored Lauren Nephew MD, MSCE for her outstanding leadership and dedication to the @aasldtweets Diversity, Equity, and Inclusion Committee over the past 6 years. 🙌🏽💼✨ #LiverTwitter

Fantastic debrief on #MASLD by Alina Allen @ #TLM2024 Yaron Rotman Rohit Loomba Naim Alkhouri Juan Pablo (JP) Arab, MD  Naga Chalasani Melina Manolas, MD, MPH Qasim Khan, MBBS, MS, FRCPC Elliot Tapper #livertwitter

Very important data further validating FGF21 as a therapeutic target for MASH. The one and only and my BFF Mazen Noureddin, MD, MHSc presenting the data 👏. AASLD Arizona Liver Health Juan Pablo (JP) Arab, MD  Jasmohan Bajaj Siemens Healthineers Echosens Naga Chalasani FattyLiverAlliance

Important read even after nearly 3 decades of NIH grant submission journey. I will read it old fashion - print & with highlighting

Strong work from IU liver transplant team in 2024 with 215 transplants (#5) and 94.85% 1-year survival on the recent SRTR report. Indiana University Gastroenterology and Hepatology, Indiana Surgery -Indiana Univ School of Medicine, IU Health, IN Donor Network

Our new review with esteemed colleagues from the FDA, Lilly, and UNC AASLD Assessment of liver injury potential of investigational medicines in drug development pubmed.ncbi.nlm.nih.gov/39999469/ Lily Dara AASLD Raj VuppaLanchi Sitaramaraju Yarramraju Ajay Duseja

Congrats David Kleiner Your contributions are magnificent and are beyond 2005 Hepatology paper. Very generous to collaborators.

📚 This #ManuscriptMonday, check out Drs. Ghabril, Vuppalanchi, & Naga Chalasani’s review! #LiverTwitter Liver International 💊 DILI from meds & supplements 🏥 CLD patients are at higher risk ⚠️ Can lead to acute-on-chronic liver failure 🔗 ow.ly/5tZ450VbSKr

A very nice review of DILI in patients with underlying CLD.

Early experience with resmetirom to treat MASH by Indiana University Gastroenterology and Hepatology pubmed.ncbi.nlm.nih.gov/40178494/ -High d/c rate due to GI AEs -Need close f/u early to manage GI AEs -Certainly not "prescribe & forget" like DAAs Madrigal Pharmaceuticals Raj VuppaLanchi Naim Alkhouri mazen noureddin Elliot Tapper

Very important work from Lauren Nephew MD, MSCE on barriers faced by marginalized individuals for curative HCC Tx. Marina Serper, MD, MS National Cancer Institute Elliot Tapper @fahisakanwal

Best study out there on sickle cell anemia and the liver by Maya Deeb 🇨🇦 In Hepatology Communications journals.lww.com/hepcomm/fullte…

Indiana innovating in liver disease care Telehepatology consults to improve care at referral hospitals, avoiding transfers. Leaders: Raj VuppaLanchi Naga Chalasani DOI: 10.1056/CAT.24.0412 NEJM Catalyst

Very important work from Indiana University Gastroenterology and Hepatology Archita Desai Elliot Tapper what do you think?